Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Serum Biomarkers for the Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): An Update.
Journal: Clinical chemistry
Published: November 01, 2025
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency-Associated Liver Disease.
Journal: Gastroenterology
Published: October 08, 2025
Metabolite perturbations in type 1 diabetes associated with metabolic dysfunction-associated steatotic liver disease.
Journal: Frontiers in endocrinology
Published: September 23, 2024
Alpha-1-Antitrypsin Pi*MZ variant increases risk of developing hepatic events in nonalcoholic fatty liver disease patients.
Journal: Clinics and research in hepatology and gastroenterology
Published: October 26, 2022
The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study.
Journal: Journal of clinical and experimental hepatology
Published: January 10, 2022
Effect of travel distance and rurality of residence on initial surveillance for hepatocellular carcinoma in VA primary care patient with cirrhosis.
Journal: Health services research
Published: November 26, 2019
Predictive Factors and Time to Development of Hepatic Decompensation in Patients with Non-alcoholic Fatty Liver Disease.
Journal: Journal of general internal medicine
Published: July 17, 2019
Support and Assessment for Fall Emergency Referrals (SAFER 1): cluster randomised trial of computerised clinical decision support for paramedics.
Journal: PloS one
Published: March 27, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026